Description
Linajen (Linagliptin 5mg) is a prescription-only DPP-4 inhibitor medication used to improve glycemic control in adults with type 2 diabetes. It works by increasing insulin release after meals and reducing liver glucose production. Taken once daily with or without food, it does not typically require dosage adjustments for kidney or liver impairment.
Key Product Details
- Active Ingredient: Linagliptin 5mg
- Drug Class: Dipeptidyl peptidase-4 (DPP-4) inhibitor
- Purpose: Type 2 diabetes mellitus management
- Dosage Form: Oral tablet
- Standard Dosage: 5mg (one tablet) once daily
Mechanism of Action
Linajen works by blocking the enzyme DPP-4, which breaks down incretin hormones (GLP-1 and GIP). By keeping these hormones active, it increases insulin secretion and reduces glucagon levels in a glucose-dependent manner, resulting in lower blood sugar levels.
Linajen works by blocking the enzyme DPP-4, which breaks down incretin hormones (GLP-1 and GIP). By keeping these hormones active, it increases insulin secretion and reduces glucagon levels in a glucose-dependent manner, resulting in lower blood sugar levels.
Clinical Information
- Administration: Swallow whole with water, daily at the same time.
- Benefits: No renal or hepatic dosage adjustment required.
- Side Effects: Potential side effects include hypoglycemia (when used with other diabetes medications), nasopharyngitis, coughing, and pancreatitis.
- Contraindications: Not for type 1 diabetes or treatment of diabetic ketoacidosis.
Storage
Store in the original package at room temperature (below 30°C), away from moisture and light.
Store in the original package at room temperature (below 30°C), away from moisture and light.
Reviews
There are no reviews yet.